Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure
about
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectivenessImmunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings.Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West AfricaEvolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.
P2860
Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evolution of HIV resistance mu ...... egimen after virologic failure
@ast
Evolution of HIV resistance mu ...... egimen after virologic failure
@en
type
label
Evolution of HIV resistance mu ...... egimen after virologic failure
@ast
Evolution of HIV resistance mu ...... egimen after virologic failure
@en
prefLabel
Evolution of HIV resistance mu ...... egimen after virologic failure
@ast
Evolution of HIV resistance mu ...... egimen after virologic failure
@en
P2093
P2860
P1476
Evolution of HIV resistance mu ...... egimen after virologic failure
@en
P2093
Daniel R McClernon
Greg McMillan
Keith A Pappa
Marty St Clair
Monique R Ferguson
William A O'Brien
Xueliang Han
P2860
P304
P356
10.1097/01.QAI.0000245882.28391.0C
P407
P577
2006-12-01T00:00:00Z